Cell proliferation and neuroblast differentiation in the dentate gyrus of high-fat diet-fed mice are increased after rosiglitazone treatment

Journal of Veterinary Science

Volumn 15, Issue 1, 2014, Pages 27-33

  Yoo, Dae Young ^a   Kim, Woosuk ^a   Kim, Dae Won ^b   Nam, Sung Min ^a   Jung, Hyo Young ^a   Kim, Jong Whi ^a   Lee, Choong Hyun ^c   Choi, Jung Hoon ^d   Won, Moo Ho ^e   Yoon, Yeo Sung ^a   Hwang, In Koo ^a  

^a Seoul National University   (South Korea)

^b Gangneung Wonju National University   (South Korea)

^c Dankook University   (South Korea)

^d Department of Anatomy College of Veterinary Medicine   (South Korea)

^e Kangwon National University   (South Korea)

Author keywords

brain derived neurotrophic factor; dentate gyrus; high fat diet; rosiglitazone

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; DOUBLECORTIN PROTEIN; KI 67 ANTIGEN; MICROTUBULE ASSOCIATED PROTEIN; NEUROPEPTIDE; ROSIGLITAZONE;

ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; CELL PROLIFERATION; DENTATE GYRUS; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LIPID DIET; LOW FAT DIET; MALE; METABOLISM; NERVOUS SYSTEM DEVELOPMENT; PHYSIOLOGY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DIFFERENTIATION; CELL PROLIFERATION; DENTATE GYRUS; DIET, FAT-RESTRICTED; DIET, HIGH-FAT; HIPPOCAMPUS; HYPOGLYCEMIC AGENTS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MICE, INBRED C57BL; MICROTUBULE-ASSOCIATED PROTEINS; NEUROGENESIS; NEUROPEPTIDES; THIAZOLIDINEDIONES;

EID: 84896340005     PISSN: 1229845X     EISSN: 1976555X     Source Type: Journal    
DOI: 10.4142/jvs.2014.15.1.27     Document Type: Article

References (40)

1. Boitard C, Etchamendy N, Sauvant J, Aubert A, Tronel S, Marighetto A, Layé S, Ferreira G. Juvenile, but not adult exposure to high-fat diet impairs relational memory and hippocampal neurogenesis in mice. Hippocampus 2012, 22, 2095-2100.
2. Brown JP, Couillard-Després S, Cooper-Kuhn CM, Winkler J, Aigner L, Kuhn HG. Transient expression of doublecortin during adult neurogenesis. J Comp Neurol 2003, 467, 1-10.
3. Chan JP, Cordeira J, Calderon GA, Iyer LK, Rios M. Depletion of central BDNF in mice impedes terminal differentiation of new granule neurons in the adult hippocampus. Mol Cell Neurosci 2008, 39, 372-383.
4. Cooper-Kuhn CM, Kuhn HG. Is it all DNA repair? Methodological considerations for detecting neurogenesis in the adult brain. Brain Res Dev Brain Res 2002, 134, 13-21.
5. Craft S, Watson GS. Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 2004, 3, 169-178.
6. Eriksson PS, Perfilieva E, Björk-Eriksson T, Alborn AM, Nordborg C, Peterson DA, Gage FH. Neurogenesis in the adult human hippocampus. Nat Med 1998, 4, 1313-1317.
7. Esposito G, Scuderi C, Valenza M, Togna GI, Latina V, De Filippis D, Cipriano M, Carratù MR, Iuvone T, Steardo L. Cannabidiol reduces Aß-induced neuroinflammation and promotes hippocampal neurogenesis through PPAR? involvement. PLoS One 2011, 6, e28668.
8. Franklin KBJ, Paxinos G. The Mouse Brain in Stereotaxic Coordinates. Academic Press, San Diego, 1997.
9. Giaginis C, Tsourouflis G, Theocharis S. Peroxisome proliferator-activated receptor-? (PPAR-?) ligands: novel pharmacological agents in the treatment of ischemia reperfusion injury. Curr Mol Med 2008, 8, 562-579.
10. Greenwood CE. Winocur G. High-fat diets, insulin resistance and declining cognitive function. Neurobiol Aging 2005, 26 (Suppl), S42-45.
11. Heneka MT, Landreth GE. PPARs in the brain. Biochim Biophys Acta 2007, 1771, 1031-1045.
12. Hwang IK, Kim IY, Kim DW, Yoo KY, Kim YN, Yi SS, Won MH, Lee IS, Yoon YS, Seong JK. Strain-specific differences in cell proliferation and differentiation in the dentate gyrus of C57BL/6N and C3H/HeN mice fed a high fat diet. Brain Res 2008, 1241, 1-6.
13. Hwang IK, Kim IY, Kim YN, Yi SS, Park IS, Min BH, Doo HK, Ahn SY, Kim YS, Lee IS, Yoon YS, Seong JK. Comparative study on high fat diet-induced 4-hydroxy- 2E-nonenal adducts in the hippocampal CA1 region of C57BL/6N and C3H/HeN mice. Neurochem Res 2009, 34, 964-972.
14. Islam O, Loo TX, Heese K. Brain-derived neurotrophic factor (BDNF) has proliferative effects on neural stem cells through the truncated TRK-B receptor, MAP kinase, AKT, and STAT-3 signaling pathways. Curr Neurovasc Res 2009, 6, 42-53.
15. Jarrard LE. On the role of the hippocampus in learning and memory in the rat. Behav Neural Biol 1993, 60, 9-26.
16. Jin J, Albertz J, Guo Z, Peng Q, Rudow G, Troncoso JC, Ross CA, Duan W. Neuroprotective effects of PPAR-? agonist rosiglitazone in N171-82Q mouse model of Huntington's disease. J Neurochem 2013, 125, 410-419.
17. Jones JR, Barrick C, Kim KA, Lindner J, Blondeau B, Fujimoto Y, Shiota M, Kesterson RA, Kahn BB, Magnuson MA. Deletion of PPAR? in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Proc Natl Acad Sci U S A 2005, 102, 6207-6212.
18. Kanakasabai S, Pestereva E, Chearwae W, Gupta SK, Ansari S, Bright JJ. PPAR? agonists promote oligodendrocyte differentiation of neural stem cells by modulating stemness and differentiation genes. PLoS One 2012, 7, e50500.
19. Kapadia R, Yi JH, Vemuganti R. Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Front Biosci 2008, 13, 1813-1826.
20. Kaundal RK, Sharma SS. Peroxisome proliferator-activated receptor gamma agonists as neuroprotective agents. Drug News Perspect 2010, 23, 241-256.
21. Kempermann G, Kuhn HG, Gage FH. Genetic influence on neurogenesis in the dentate gyrus of adult mice. Proc Natl Acad Sci U S A 1997, 94, 10409-10414.
22. Kempermann G, Kuhn HG, Gage FH. More hippocampal neurons in adult mice living in an enriched environment. Nature 1997, 386, 493-495.
23. Kersten S, Desvergne B, Wahli W. Roles of PPARs in health and disease. Nature 2000, 405, 421-424.
24. Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, Satoh S, Nakano R, Ishii C, Sugiyama T, Eto K, Tsubamoto Y, Okuno A, Murakami K, Sekihara H, Hasegawa G, Naito M, Toyoshima Y, Tanaka S, Shiota K, Kitamura T, Fujita T, Ezaki O, Aizawa S, Nagai R, Tobe K, Kimura S, Kadowaki T. PPAR? mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 1999, 4, 597-609.
25. Launer LJ. Demonstrating the case that AD is a vascular disease: epidemiologic evidence. Ageing Res Rev 2002, 1, 61-77.
26. Lee CH, Choi JH, Yoo KY, Park OK, Moon JB, Sohn Y, Cho JH, Hwang IK, Won MH. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor ?, decreases immunoreactivity of markers for cell proliferation and neuronal differentiation in the mouse hippocampus. Brain Res 2010, 1329, 30-35.
27. Lee J, Duan W, Mattson MP. Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J Neurochem 2002, 82, 1367-1375.
28. Mctigue DM, Tripathi R, Wei P, Lash AT. The PPAR gamma agonist Pioglitazone improves anatomical and locomotor recovery after rodent spinal cord injury. Exp Neurol 2007, 205, 396-406.
29. Miglio G, Rattazzi L, Rosa AC, Fantozzi R. PPAR? stimulation promotes neurite outgrowth in SH-SY5Y human neuroblastoma cells. Neurosci Lett 2009, 454, 134-138.
30. Park HR, Park M, Choi J, Park KY, Chung HY, Lee J. A high-fat diet impairs neurogenesis: involvement of lipid peroxidation and brain-derived neurotrophic factor. Neurosci Lett 2010, 482, 235-239.
31. Sairanen M, Lucas G, Ernfors P, Castrén M, Castrén E. Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J Neurosci 2005, 25, 1089-1094.
32. Schintu N, Frau L, Ibba M, Caboni P, Garau A, Carboni E, Carta AR. PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease. Eur J Neurosci 2009, 29, 954-963.
33. Schmidt HD, Duman RS. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol 2007, 18, 391-418.
34. Sodhi RK, Singh N, Jaggi AS. Neuroprotective mechanisms of peroxisome proliferator-activated receptor agonists in Alzheimer's disease. Naunyn Schmiedebergs Arch Pharmacol 2011, 384, 115-124.
35. Sundararajan S, Landreth GE. Antiinflammatory properties of PPARgamma agonists following ischemia. Drug News Perspect 2004, 17, 229-236.
36. Vidal-Puig A, Jimenez-Liñan M, Lowell BB, Hamann A, Hu E, Spiegelman B, Flier JS, Moller DE. Regulation of PPAR ? gene expression by nutrition and obesity in rodents. J Clin Invest 1996, 97, 2553-2561.
37. Wang S, Sun Z, Guo Y, Yuan Y, Li L. PPAR?-mediated advanced glycation end products regulation of neural stem cells. Mol Cell Endocrinol 2009, 307, 176-184.
38. Yoo DY, Kim W, Nam SM, Yoo KY, Lee CH, Choi JH, Won MH, Hwang IK, Yoon YS. Reduced cell proliferation and neuroblast differentiation in the dentate gyrus of high fat diet-fed mice are ameliorated by metformin and glimepiride treatment. Neurochem Res 2011, 36, 2401-2408.
39. Yoo DY, Shin BN, Kim IH, Kim W, Kim DW, Yoo KY, Choi JH, Lee CH, Yoon YS, Choi SY, Won MH, Hwang IK. Effects of Cu,Zn-superoxide dismutase on cell proliferation and neuroblast differentiation in the mouse dentate gyrus. Neurochem Res 2012, 37, 261-267.
40. Zhao X, Ou Z, Grotta JC, Waxham N, Aronowski J. Peroxisome-proliferator-activated receptor-gamma (PPAR?) activation protects neurons from NMDA excitotoxicity. Brain Res 2006, 1073-1074, 460-469.